ACO Model Calls for Health Care Delivery System Overhaul

Share this content:
ACO Model Calls for Health Care Delivery System Overhaul
ACO Model Calls for Health Care Delivery System Overhaul

(HealthDay News) -- The accountable care organization (ACO) model requires an overhaul for health care delivery, according to an article published in Medical Economics.

The author of the article, Susan Kreimer, discusses why the ACO model has succeeded in some cases and failed in others.

According to Kreimer, the ACO model stresses quality and curbing costs while focusing on creating a healthier population. Incentives are created based on the population's use of services, encouraging ACOs to improve the quality of care for all its patients.

RELATED: Practice Management Resource Center

Preliminary results seem positive for ACOs, although whether the improvements in quality measures will lead to cost savings remains to be seen. Major challenges are involved in acclimating to an ACO model, including overhauls to health care delivery, technology systems, operations, and governance.

Successful ACOs involve an integrated network of physicians, hospitals, and outpatient facilities, and address nonclinical factors. In addition, they have to balance financial accountability with devising a care model that works. An additional strategy classifies patients into risk-based segments and employs different clinical interventions in each group.

"The ACO model is a nice transition away from [the focus on volume over value]," said Timothy Peterson MD, MBA, from the Physician Organization of Michigan ACO, according to the Medical Economics article. "But if we do our job well, it will eventually become impossible to cut costs out of the health care delivery system without risking compromising the quality of care provided."

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs